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Coxsackie B virus protein 2B contains near its C terminus a hydrophobic domain with an amino acid 
composition that is characteristic for transmembrane regions. A molecular genetic approach was followed to 
define the role of this domain in virus reproduction and to study the structural and hydrophobic requirements 
of the domain. Nine substitution mutations were introduced in an infectious cDNA clone of coxsackie B3 virus.
The effects of the mutations were studied in vivo by transfection of Buffalo green monkey cells with copy RNA 
transcripts* The results reported here suggest that a critical degree of hydrophobicity of the domain is essential 
for virus growth. The mutations S77M, C75M, I64S, and V66S, which caused either a small increase or 
decrease in mean hydrophobicity, yielded viable viruses. The double mutations S77M/C75M and I64S/V6-6S, 
which caused a more pronounced increase or decrease in hydrophobicity, were nonviable. Negatively charged 
residues (mutations A71E, I73E, and A71E/I73E) abolished virus growth. The mutations had no effect on the 
synthesis and processing of the viral polyprotein. Replication and complementation were studied by using a 
subgenomic coxsackievirus replicon containing the luciferase gene in place of the capsid coding region. 
Analysis of luciferase accumulation demonstrated that the mutations cause primary defects in viral RNA 
synthesis that cannot be complemented by wild-type protein 2B provided in trans. The hydrophobic domain is 
predicted by computer analysis to form a multimeric transmembrane helix. The proposed interaction with the 
membrane and the implications of the mutations on this interaction are discussed.
The genus Enterovirus, a subgroup of the Picornaviridae, 
consists of the polioviruses, coxsackieviruses, echoviruses, and 
enterovirus serotypes 68  to 71. The structures, genomic orga­
nization, and molecular biology of these viruses are relatively 
well known from the extensive studies of poliovirus. Enterovi­
ruses are positive-strand R N A  viruses with a single-stranded 
genome of approximately 7,500 nucleotides (nt). A small vi- 
rally encoded protein, VPg, is covalently attached at the 5' end 
of the RNA, and a genetically encoded poly(A) tail is present 
at the 3' end (see Fig. 2A). The viral genome acts as mRNA to 
direct the synthesis of a polyprotein. Translation occurs via a 
CAP-independent binding of ribosomes to the 5' nontrans­
lated region (19, 32). The viral polyprotein is proteolytically 
processed by the virus-encoded pro teases 2Apro, 3 Cpro, and 
3CDpro to functional cleavage intermediates and the individual 
proteins. The proteins encoded by the PI region of the genome 
are capsid proteins. The nonstructural proteins encoded by the 
P2  and P3 regions are involved in viral R N A  (vRNA) replica­
tion. For more details on the genomic structure of enterovi­
ruses, we refer to a recent review of Wimmer et al. of the 
genetics of poliovirus (40).
Replication of the enterovirus R N A  genome starts with the 
synthesis of a complementary negative RN A  strand in the 
cytoplasm of the host cell by the RNA-dependent RN A  poly­
merase 3D po1 (3). Viral positive R N A  strand synthesis takes 
place in replication complexes, which are specialized structures 
composed of partially double-stranded replicative intermedi­
ates plus the replication proteins (17). Genetic and biochem­
ical studies have shown that the proteins encoded by the P3
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region are involved in vRNA synthesis within these complexes 
(40). The replication complexes are closely associated with 
virus-induced membrane vesicles (6 ). Both the initiation of 
vRNA synthesis and the release of vRNA from the complexes 
are dependent on these vesicles (7, 37, 38). The inhibition of 
poliovirus RNA replication by Brefeldin A, an antibiotic that 
blocks membrane traffic between the endoplasmic reticulum 
(ER) and the Golgi apparatus and between the cis and trans 
Golgi apparatus, further indicates that intact secretory path­
way traffic is required for vRNA replication (14, 18, 28).
Enterovirus proteins 2B, 2C, and 2BC seem to be involved in 
the functional and structural organization of the replication 
complexes. These proteins are rough-ER (rER) associated 
soon after their synthesis and are exclusively localized at the 
cytoplasmic surface of the ER-derived membrane vesicles that 
surround the viral replication complex (5, 6 , 8 ). Electron mi­
croscopy and biochemical studies have shown that protein 2C 
or its precursor 2BC is involved in the attachment of the vRNA 
to the vesicular membranes (7, 9, 35). Furtherm ore, it has 
been shown that poliovirus protein 2C is an NTPase with both 
ATPase and GTPase activities (29, 35). The transient expres­
sion of poliovirus protein 2C or its precursor 2 BC in eucaryotic 
cells resulted in the proliferation of cellular membranes and 
accumulation of membrane vesicles in a way similar to that 
seen during virus infection, suggesting that protein 2C belongs 
to the family of small GTPases involved in the regulation of 
membrane traffic (1, 10). Enterovirus protein 2B is a small 
hydrophobic protein which has profound effects on cellular 
membranes. Mutations mapping to the N terminus of poliovi­
rus protein 2B exhibited primary defects in RNA synthesis (20, 
27). These 2B mutants displayed a dosage-dependent domi­
nance over wild-type virus, which led to the suggestion that 
protein 2B plays a structural role in the viral replication com­
plexes, possibly by interacting with a limiting membrane at-
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Hydropathy of CBV3 protein 2B
FIG. 1. (A) Hydropathy plot of CBV3 protein 2B according to Kyte and 
Doolittle (24). The hydropathy window size used for this plot is 9 residues. 
Positive hydropathy indicates a hydrophobic nature. The numbers of amino acid 
residues are indicated on the ordinate. (B) Alignment of the amino acid se­
quences of the 2B proteins of enteroviruses for which sequences are known. The 
enteroviruses are divided into a CBV-like subgroup and a poliovirus-like sub­
group. Enteroviruses with distinct amino acid sequences are shown apart. In this 
alignment, we have included the 2B amino acid sequences of live nonrelated 
CBVI isolates with highly divergent 2AP'° regions (41), Virus propagation, RNA 
extraction, reverse transcription, amplification by PCR, and sequence analysis of 
the 2B coding regions of these five CBVI isolates were performed as described 
elsewhere (41). Abbreviations: CAV, coxsackie A virus; ECHO, echovirus; 
SVDV, swine vesicular disease virus; CBVlTuc, myotropic CBVI strain Tucson; 
CBVlIsr, strain isolated 23 July 1978 from an immigrant child fiv^y, 
CBVlNet, strain isolated in 1992 from a patient in The Netherlands; CBVlCol, 
strain isolated 1 April 1986 from an immigrant child from Colombia; CBVlsur, 
strain isolated 6 July L9S1 from surface water in The Netherlands; PV 1(M), 
poliovirus type I strain Mahoney; PV2(L), poliovirus type 2 strain Lansing; 
PV3(L), poliovirus type 3 strain Leon; EV70, enterovirus type 70; BEV1, bovine 
enterovirus type 1 .
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tachment site (20). The expression of both poliovirus and cox­
sackie B3 virus (CBV3) protein 2B in Escherichia coli resulted 
in a modified membrane permeability (26, 39a). Recently, it 
has been shown that the expression of poliovirus protein 2B in 
eucaryotic cells leads to permeabilization of the cell membrane 
and inhibition of secretory pathway function (13). These ob­
servations suggest that enterovirus protein 2B is a membrane- 
active protein which may be involved in the accumulation of 
membrane vesicles for vRNA replication.
The regions of protein 2B that are involved in the interaction 
with the E R  membrane are not yet known. Membrane anchors 
are typically composed of mainly hydrophobic amino acids and 
a significant portion of serine and threonine residues (15). 
About 18 amino acid (aa) residues are required to span the E R  
membrane (31). Analysis of the hydropathy of CBV3 protein 
2B according to the method described by Kyte and Doolittle
(24) demonstrates the existence of two hydrophobic domains 
(Fig. 1A). The hydrophobicity of these domains is well con­
served in all enteroviruses, despite extensive differences in 
amino acid sequence am ong mem bers of the CBV-like and 
poliovirus-like subgroups (Fig. IB). The hydrophobic domain 
near the C terminus of CBV3 protein  2B is composed of a 
stretch of 18 aa (aa 63 to 80) which is devoid of charged 
residues. The amino acid composition of this hydrophobic do­
main is characteristic for transm em brane domains, since it 
contains 12 hydrophobic aa, 4 threonine residues, and 2 serine 
residues. The importance of this dom ain is reflected in the 
conservation of the hydrophobic features among all enterovi­
ruses. The limited intratypic sequence heterogeneity found in 
five CBVI isolates containing divergent 2A coding regions (41) 
further strengthens the im portance of conservation in this re ­
gion of protein 2B (Fig. IB).
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To examine the structural and hydrophobic requirements of 
this domain and to define its role in viral l'eproduction, we have 
constructed nine CBV3 protein 2B mutants. The effect of the 
mutations on virus viability was assayed by transfection of 
Buffalo green monkey (BGM ) cells with copy RNA transcripts. 
Translation and processing of the viral polyprotein were ex­
amined both in vitro and in vivo. Replication and complemen­
tation of the mutants were tested by introduction and analysis 
of the mutations in a subgenomic replicon in which the capsid- 
coding region had  been  replaced by the luciferase gene. The 
results reported  here indicate that a moderate degree of hy­
d rophob ia  ty of the  domain is essential for the function of 
protein 2B. M utations which caused a major increase or de­
crease in hydrophobicity as well as the introduction of nega­
tively charged residues interfered with virus growth. These 
mutations caused primary defects in vRNA  synthesis that 
could not be complemented in trans by wild-type protein 2B. 
The proposed interaction of this hydrophobic domain with the 
membrane and the implications of the mutations on this inter­
action are discussed,
MATERIALS AND METHODS
Coils and viruses. Virus propagations and RNA transfections were performed 
with BGM cells. Plaque assays were performed with Vero cells. The cells were 
grown in minimal essential medium (MEM) (GIBCO) supplemented with 10% 
fatal bovine serum (GIBCO). After infection, cells were fed with MEM contain­
ing 3% fetal bovine serum. After transfection, MEM containing 10% fetal bovine 
serum was added to the cells. Virus yields were determined by endpoint titration. 
Serial 10-fold dilutions were tested in 8 replicative wells of 96-well plates con­
taining BGM cell monolayers (36). Virus titers were calculated according to the 
method described by Reed and Muench and were expressed in 50% tissue 
culture infective dose (TCID50) values (34).
Oligonucleotide-directed site-specific mutagenesis. Plasmid pCB3/T7 was 
kindly provided by R, Kandolf (University of Tübingen, Tübingen, Germany). 
This plasmid contains a full-length copy DNA of CBV3 (strain Nancy) cloned 
behind a T7 RNA polymerase promoter (22), In vitro mutagenesis was per­
formed with the Altered Sites in vitro mutagenesis system (Promega) according 
to the recommendations of the manufacturer. For mutagenesis, the Hindlll (nt 
2080) to Xbal (nt 4947) fragment of pCB3/T7 was introduced in phagemid 
pALTER-1 to generate pALTCB3/2080-4947. Synthetic oligonucleotides were 
used to introduce site-specific mutations. The nucleotide sequence of the mutant 
pALTCB3 clones wavs verified by dideoxy chain termination sequence analysis of 
plasmid DNA with oligonucleotide 5'-CCATTCAATGAATTTCTG-3' (comple­
mentary to nt 4117 to 4134) with the Ampli Cycle sequencing kit according to the 
instructions of the manufacturer (Perkin-Elmer). From these clones, the Spel (nt 
3837)-to-iterH.II (nt 4238) fragment was cloned in pCB3/T7.
Transcription and transfection of cells with copy RNA transcripts. Plasmids 
were linearized by digestion with Sail, extracted with phenol-chloroform, and 
precipitated. Copy RNA transcripts were generated in a 100-^xl reaction mixture 
containing 2 jxg of linearized template DNA, 40 mM Tris-HCl (pH 7.5), 10 mM 
NaCI, 6 mM MgCl2, 2 mM spermidine, 2.5 mM each nucleoside triphosphate, 
100 U of RNAsin (Promega), and 30 U of T7 RNÀ polymerase (Promega). Small 
portions (2 jxl) were analyzed on a 1% agarose gel. Twenty microliters of the 
transcription mixture (2 to 4 |xg of RNA) was used for transfection of BGM cells 
by the DEAE-dextran method (39) with some modifications. Briefly, 80 jjlI of a 
A/-2-hydroxyethyIpiperazine-Ar'-2-ethanesulfonic acid (HEPES)-buffered salt so­
lution (HBS) <20 mM HEPES [pH 7.05], 137 mM NaCl, 5 mM KCl, 1 mM 
Na2H P 0 4, 5.5 mM glucose) was added to a 20-p.l transcription mixture and 
mixed with 100 jxl of a DEAE-dextran solution (1 mg/ml in HBS), and the 
solution was incubated on ice for 30 min. BGM  monolayer cells grown in 25-cm2 
flasks to a confluency of 75% were washed three times with phosphate-buffered 
saline (PBS) and incubated with the RN  A-DEAE-dextran mixture for 30 min at 
room temperature. The cells were washed three times with PBS, overlaid with 
cell culture medium, and incubated at either 33 or 36°C for the times indicated 
in the text "When vims growth was observed, the cultures were incubated until 
cy to path ic effect (CPE) was complete. The cultures were then subjected to three 
cycles of freezing and thawing, and the viruses were aliquoted in stocks of 1 ml 
and stored at -S0°C.
Sequence analysis of the 2B coding region of m utant viruses. RNA was 
isolated from 100 p.1 of virus stock by a single extraction procedure with guani­
dinium thiocyanate-phenol-chloroform according to the method described by 
Chomczynski and Sacchi (1 1 ). Reverse transcription of RNA and amplification 
of cDNA by PCR with forward primer 5 ' -G C AAT G G AAC AG G G AGTG A AG 
GACTATGTGGA-3' (nt 3733 to 3765) and reverse primer 5 '-TTGG GA TG GC 
GCGCTCTGCTC-3' (nt 4231 to 4251) were performed as described previously 
(42). The resulting 519-bp PCR products were purified by low-melting-point
agarose gel electrophoresis. Sequence analysis of the PCR products was per­
formed as described above.
Plaque assays. Plaque assays were carried out with 100% confluent monolay­
ers of Vero cells on 10-cm2 dishes in 6-well plates. Virus dilutions were made in 
MEM containing 3% fetal bovine serum. Vero cells were infected with diiferent 
virus dilutions and incubated for 30 min at room temperature. After removal of 
the inoculum, the cells were overlaid with 5 ml of cell culture medium containing 
1% plaque agarose (Servo) and 25 mM MgCI2. The cells were grown at 33, 36, 
and 39°C, and plaque phenotypes were analyzed at 3 to 5 days postinfection.
Single-cycle growth analysis. BGM cell monolayers grown in 25-cm2 flasks (5 
X TO6 cells per flask) were infected with virus at a multiplicity of infection (MOI) 
of 1 TCID50 per cell. After 30 min of adsorption, the cells were washed three 
times with MEM and 5 ml of cell culture medium was added. The cells were 
incubated at 33, 36, or 39°C for 2, 4, 6, or 8 h. Viruses were released by three 
successive cycles of freezing and thawing. Virus titers were determined by titra­
tion on BGM cell monolayers in 96-well plates.
Construction of subgcnomic replicon pCB3/T7-XAJC. For the substitution of 
the capsid-coding region by the luciferase coding sequence, the PI capsid-coding 
region was deie'ed from pCB3/T7 by two subsequent PCR product subcloning 
steps by using the unique restriction sites for Sftil (nt 250), Bglll (nt 2024), and 
BííHII (nt 4238). PCRs were performed with ULTma DNA polymerase (Perkin- 
Elmer), a DNA polymerase containing proofreading activity. First, nt 243 to 745 
were amplified with primers 5'-AAC TAC TTC GAA AAA CCT AGT AAC 
ACC-3' (nt 243 to 269) and 5 '-TTG CGT AGA TCT GCG GCC G C C CATTTT 
GCT GTA TTC AAC TTA-3' (complementary to nt 721 to 745 plus restriction 
sites, which are underlined, for Notl and Bglll). This PCR product was cut with 
Sful and Bglll and cloned in pCB3/T7 cut with the same enzymes. In the resulting 
plasmid, pCB3/T7-A746/2024, the N-terminal half of the PI region is deleted. 
Second, nt 3280 to 4251 were amplified with primers 5 '-ACT ACT AGG AGA 
TCT GTT AAC ACA ATG ACA AAT ACG GGC GCA-3' (nt 3280 to 3300 
plus restriction sites for Bglll and Hpal) and 5’-TTG GGA TGG CGC GCT 
CTG CTC-3* (complementary to nt 4231 to 4251). This PCR product was cut 
with Bglil and S&vHII and introduced in pCB3/T7-A746/2024 cut with the same 
enzymes. In the resulting plasmid (pCB3/T7-APl), nt 746 to 3279 of the PI 
coding region are deleted and replaced by the sequence GGC GGC CGC AGA 
TCT GTT AAC (the restriction sites for Noil, Bglll, and Hpal, respectively). 
Except for its initiation and stop codon, the firefly luciferase gene was amplified 
by PCR with plasmid pGEM-luc (Promega) as template with primers 5'-GCC 
CGG AGC GGC CGC GAA GAC GCC AAA AAC ATA-3' and 5 '-AGT TAC 
GTT AAC CAA TTT GGA CTT TCC GCC-3', cut with Notl and Hpal, and 
cloned in pCB3/T7-APl cut with the same enzymes. The resulting plasmid was 
designated pCB3/T7-LUC (see Fig. 4A). Because of the cloning procedure, the 
luciferase product contains three additional amino acids (Gly-Gly-Arg), which 
correspond to the Notl site, after the initial methionine. The guanidine residue 
following the initiation codon was retained in order to keep the Kozak consensus 
sequence intact (23). Furthermore, luciferase contains seven additional residues 
at its C terminus. The Val and Asn residues correspond to the Hpal site. The five 
C-terminal amino acids of VP1 were retained to ensure a correct proteolytic 
processing by 2Apro.
Analysis of viral positive RNA synthesis. BGM cell monolayers grown in 
25-cm2 flasks to a confluency of 75% were transfected with 0.5 to 1.0 jxg of T7 
RNA polymerase-generated pCB3/T7-LUC copy RNA derived from Sfl/I-Iinear- 
ized plasmids. At the indicated times posttransfection, the cells were washed 
three times with PBS and lysed in 400 jxl of lysis bulfer, and the luciferase activity 
was measured in a liquid scintillation counter with the luciferase assay system 
according to the recommendations of the manufacturer (Promega).
In vitro translation reactions. Copy RNA transcripts were synthesized and 
translated in T7 TNT rabbit reticulocyte lysate (Promega) according to the 
manufacturer’s recommendations. The translation reaction mixtures (20 fxl) 
were programmed with 0.5 |xg of Sa/I-linearized plasmid DNA and supple­
mented with 20% (vol/vol) HeLa cell initiation factors (kindly provided by J. 
Flanegan, University of Florida). In vitro-synthesized proteins were labeled with 
20 (xCi of [33S]cysteine (specific activity, >1,000 Ci/mmol; Amersham) for 3 h at 
30°C. After this incubation, RNA was degraded by treatment with RNase T, (500 
U) and RNase A (5 fig) for 10 min at 30°C. Translation products (5 jxl) were 
analyzed on a 12.5% polyacrylamide gel containing sodium dodecyl sulfate 
(SDS) (25). The gels were fixed in 30% methanol-10% acetic acid, rinsed in 
dimethyl sulfoxide, fluorographed with 20% 2,5-diphenyloxazole in dimethyl 
sulfoxide, dried under vacuum, and exposed to Kodak XAR film at -80°C.
Analysis of viral protein synthesis in vivo. BGM monolayer cells (2 X 105) 
were infected with either wild-type or mutant viruses at a MOI of 50. After virus 
adsorption for 30 min at room temperature, medium was added and the cells 
were incubated at 36°C. At various times postinfection, the cells were washed for 
three times with PBS and pulse-labeled in methionine- and serum-free MEM 
(GIBCO) containing 10 jxCi of Tran35 S-label (a mixture of [35S]methionine and 
[35S]cysteine; specific activity, >1,000 Ci/mmol; ICN). After 1 h, the medium was 
removed and the cells were lysed in cold lysis buffer containing 500 mM Tris-HCl 
(pH 8.0), 150 mM NaCI, 0.1 mM phenylmethylsulfonyl fluoride, 1% Nonidet 
P-40 and 0.05% SDS. Labeled proteins were analyzed by polyacrylamide gel 
electrophoresis as described above.
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FIG. 2. (A) Schematic structure of the genome of CBV3 showing the 7.5-kb single-stranded RNA genome with the covalently bound VPg protein at the 5' end of 
the nontranslated region (NTR) and the genomic encoded poIy(A) tract at the end of the 3' NTR. The boxed region shows the polyprotein containing the structural 
PI region proteins and the nonstructural P2 and P3 region proteins. Also shown is the partial amino acid sequence of protein 2B including the hydrophobic domain 
formed by aa 63 to 80 (which is underlined) and the mean < H >  per residue of this domain acunrding to Eisenberg et al. (15). (B) aa 63 to 80 of the pCB3/T7 2B mutant 
plasmids, the mean < H >  per residue of this hydrophobic region, and the effect of the mutations on virus growth.
RESULTS
Introduction of mutations in a hydrophobic domain of 
CBV3 protein 2B. Nine CBV3 mutants containing amino acid 
substitutions in a hydrophobic 18-residue domain of protein 2B 
were constructed by site-directed mutagenesis. The mutations 
were verified by sequence analysis and introduced in the in­
fectious cDNA clone pCB3/T7. The integrity of the resulting 
plasmids was checked by restriction enzyme analysis. Figure 2 
shows the genotypes of the mutants and the predicted effects of 
the mutations on hydrophobicity. On the basis of the effects of 
the mutations on the mean hydrophobicity and net charge of 
this region, the pCB3/T7 2B mutants can be divided into three 
groups as follows, (i) In mutants 2B-S77M, 2B-C75M, and 
2B-S77M/C75M, serine 77 (TCG) and cysteine 75 (TGT) were 
replaced by more-hydrophobic methionine (ATG) residues,
(ii) In mutants 2B-I64S, 2B-V66S, and 2B-I64S/V66S, the 
mean hydrophobicity is decreased by substitution of hydropho­
bic residues isoleucine 64 (ATC) and valine 66 (GTG) by polar 
serine residues (codons A G T and TCG, respectively), which 
contain alipathic hydroxy] side chains, (iii) In mutants 2B- 
A71E, 2B-I73E, and 2B-A71E/173E, the mean hydrophobicity 
is decreased by the replacement of alanine 71 (GCC) and 
isoleucine 73 (ATC) by negatively charged glutamic acid 
(GAG) residues.
Effect of the mutations on virus growth. The effect of the 
mutations on virus viability was studied by transfection of 
BGM cells with copy RN A  transcripts. For each mutant, eight 
transfections were performed. Four transfected cell cultures 
were incubated at 33°C, and four were incubated at 36°C. Cells 
transfected with copy RNA of mutants 2B-S77M, 2B-I64S, and 
2B-V66S exhibited complete CPE at 48 to 72 h posttransfec­
tion, which is similar to that of wild-type pCB3/T7. Transfec­
tion of copy RNA of mutant 2B-C75M showed a delayed virus 
growth. Complete CPE was not observed before 72 to 96 h 
posttransfection. No CPE was observed up to 5 days posttrans­
fection at either 33 or 36°C after transfection with copy RNAs 
of mutants 2B-S77M/C75M, 2B-I64S/V66S, 2B-A71E, 2B- 
173E, and 2B-A71 E/173E. These cell cultures were subjected to
three cyclcs of freezing and thawing, and 250 |xl was subse­
quently passaged to fresh B G M  cell monolayers. CPE was 
observed after passage of one of the cell cultures transfected 
with copy RNA of m utan t 2B-S77M/C75M (see the following 
paragraph), but no t after passage of cells transfected with copy 
RNAs of any of the oilier mutants.
Sequence analysis of the 2B coding region of the viable 
mutant viruses showed th a t  the original mutations introduced 
by site-specific mutagenesis were retained in the vRNA and 
that no other amino acid replacements had occurred. Viral 
growth characteristics were examined by plaque assays and 
single-cycle growth analysis. Viruses vCB3~2B-S77M, -I64S, 
and -V6 6 S exhibited wild-type growth. Virus vCB3-2B-C75M 
exhibited a small-plaque phenotype (Fig. 3). In single-cycle 
infections, this virus produced 3 and 5% of the wild-type virus 
yield a t 6 and 8 h postinfection, respectively (data not shown). 
All m utant viruses showed similar reproductive capacities at 
33, 36, and 39°C, which indicates that none of the mutations 
caused temperature-sensitive growth defects. The results of the 
transfections and the characterization of the viable mutants are 
summarized in Fig. 2B.
Isolation of two revertan t viruses. Passage of cells trans­
fected with copy R N A  of m utan t 2B-S77M/C75M revealed 
virus growth in one of the cultures grown at 33QC. Sequence 
analysis demonstrated tha t these viruses still contained the 
methionine at position 77 bu t a reversion of the introduced 
methionine (AUG ) at position 75 to a valine (G U G ) residue. 
This partial revertant virus, vCB3-2B-S77M/C75V, exhibited a 
small-plaque phenotype at all tem peratures (data not shown). 
In single-cycle infections, this m utan t produced 10 and 20% of 
wild-type virus yield a t 6  and 8  h postinfection, respectively 
(data not shown). Amplification and sequence analysis of "the 
2B coding region of virus from the primary transfected culture 
showed that the reversion had  already occurred in the trans­
fected cells.
The plaque assay plates of m utant vCB3-2B-C75M con­
tained predominantly small plaques; however, larger plaques 
were also observed (Fig. 3). Three large plaques and three
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is restricted by both lower and upper hydrophobicity limits. 
The single amino acid substitutions that caused only minor 
alterations in hydrophobicity (S77M [< H > , 0.57], I64S [< H > , 
0.44], V 66S [< H > ,  0.45], and C75M [< H > ,  0.54]) all yielded 
viable viruses. These structural alterations and the concomi­
tant increases or decreases in mean hydrophobicity had no 
effect or only little effect (small-plaque mutation C75M) on the 
function of protein 2B in vRNA synthesis. However, both dou­
ble mutations S77M/C75M ( < H > ,  0.59) and I64S/V66S 
(<IT>, 0.37) were nonviable. Since each of the single substi­
tutions did not severely affect the structure of the domain, the 
disturbance of vRNA synthesis caused by the double mutations 
is most likely due to the more profound increase or decrease in 
the overall hydrophobicity of the domain. The suggestion that 
the hydrophobicity of the domain is restricted by an upper limit 
is further supported by the observation that revertant vCB3- 
2B-S77M/C75V ( < H > ,  0.61) exhibited a small-plaque pheno­
type, whereas viruses containing each of the single mutations 
displayed wild-type growth. The disturbance of the hydropho­
bic character of the domain by the nonviable mutations A71E 
(< H > ,  0.45), I73E ( < H > ,  0.40), and A71E/I73E (< H > ,  0.33) 
may be due to the introduction of the negative charges rather 
than to the decrease in the overall hydrophobicity of the do­
main, since the decrease caused by mutation A71E is similar to 
those caused by mutations I64S and V 66S. Another observa­
tion which cannot simply be explained by means of hydropho­
bicity is the finding that mutation C75M (< H > ,  0.54) yielded 
a small-plaque virus, whereas a revertant containing a rever­
sion of the introduced methionine 75 to a valine residue 
(< H > ,  0.57) displayed a wild-type growth. It is difficult to 
explain the adverse effect of mutation C75M. The wild-type 
growth of revertant vCB3-2B-C75V makes it unlikely that the 
sulfhydryl group of cysteine 75 is involved in the formation of 
disulfide bridges. The defect in vRNA synthesis caused by 
mutation C75M may be caused by the relatively long side chain 
of the methionine residue, which may interfere with the struc­
ture of the domain or the interaction of the domain with its 
target.
The exact function of protein 2B in vRNA replication is not 
yet known. The expression of poliovirus protein 2 B led to an 
increase in plasma membrane permeability and the inhibition 
of protein secretion (13), suggesting that protein 2B has pro­
found effects on cellular membranes. Protein 2B has a high 
affinity for membranes and becomes associated with the rER 
membrane immediately after its synthesis (5). It is likely that 
the hydrophobic domain is involved in this association and that 
major alterations in the hydrophobic domain interfere with the 
localization of protein 2B at the vesicular membrane. The 
displacement of protein 2B from the membrane may hinder a 
functional role of protein 2B in vRNA synthesis in the repli­
cation complex. Alternatively, the disturbance of the interac­
tion with the membrane may interfere with a structural role of 
protein 2B in the organization of the viral replication complex 
(20). The interaction of protein 2B with the membrane may be 
a prerequisite for the inhibition of protein secretion. Mutations 
that disturb the interaction of protein 2B with the membrane 
may interfere with the accumulation of membrane vesicles for 
vRNA synthesis and thereby account for the defects in the 
synthesis of viral positive RNA strands. However, it cannot be 
excluded on the other hand that this hydrophobic domain is 
involved in a specific interaction with another viral or cellular 
protein required for vRNA synthesis. Alterations in the hydro­
phobicity or structure of the domain would affect these pro- 
tein-protein interactions and in this way account for the ob­
served defects in vRNA synthesis.
The possible disposition of protein 2B in the membrane was
analyzed by a theoretical method. Eisenberg and coworkers 
have developed an algorithm to identify membrane-associated 
helices in membrane proteins and to distinguish them from 
helices in globular proteins (15). Candidate membrane-associ­
ated helices are identified by calculating the hydrophobicity of 
21-residue windows run over the entire protein. Candidate 
helices must have a mean < H >  value of at least 0.42. Further-
more, there must be either one highly hydrophobic helix with 
an < H >  value of at least 0,68 or two moderate hydrophobic 
helices, which may be provided either intra- wi iTiteimolccu- 
larly, with a summation value of at least 1,10. Candidate helices 
are then classified as either a monomeric transmembrane helix, 
a multimeric transmembrane helix, or a surface-seeking helix 
with the aid of the hydrophobic moment plot, on which the 
hydrophobic moment of the helix is plotted as a function of its 
hydrophobicity (15). W e have identified candidate membrane- 
associated helices in enterovirus protein 2B using 18- to 21- 
residue windows, since it has been reported that 18 aa are 
appropriate for spanning the E R  membrane (31). In members 
of the CBV-like subgroup, the most hydrophobic segment is 
formed by aa 63 to 80 ( < H >  =  0.52 to 0.60)* In members of 
the poliovirus-like subgroup, the segment with the highest 
< H >  value is formed by residues 64 to 81 ( < H >  =  0.49 to
0.55). The mean hydrophobicity of these segments is probably 
too low for the integration as a monomeric transmembrane 
helix but may be sufficient to form a multimeric transmem­
brane helix. Classification of these segments on the hydropho­
bic m om ent plot also suggests that they form multimeric trans­
membrane helices, i.e., protein  segments that are cooperatively 
associated within the lipid bilayer and stabilized by either an 
intermolecular (e.g., in the form of multimers) or an intram o­
lecular linkage with other transm em brane a-helices.
At present, there is no biochemical evidence for the predic­
tion that the hydrophobic domain forms an integral transmem­
brane helix that is associated with other transmembrane heli­
ces. However, the suggestion that the hydrophobic domain 
forms a multimeric ra ther than a monomeric transmembrane 
helix is supported by several observations made in this study, 
(i) The m ean hydrophobicity values of the mutants with wild- 
type phenotypes varied between 0.44 and 0.57. These values 
are too low for m onom eric transm em brane proteins to effi­
ciently penetrate the m em brane and maintain an energetically 
stable configuration (15). (ii) T he substitution of cysteine 75 
with a hydrophobic m ethionine residue interfered with vRNA 
synthesis, which makes it unlikely that this residue is involved 
in a hydrophobic interaction with the lipid bilaycr. (iii) The 
mutations which caused the greatest increase in the hydropho­
bicity of the domain were either lethal for virus growth (S77M/ 
C75M [ < H >  =  0.59]) or resulted in a small-plaque virus 
(S77M/C75V [ < H >  = 0.61]). This suggests that there may 
exist an upper hydrophobicity limit for the domain and that by 
exceeding this limit, the domain may become too hydrophobic 
to efficiently interact with o ther transm embrane helices,
A  complementation analysis was performed to examine 
whether the defects in vR N A  synthesis caused by the m uta­
tions in the hydrophobic domain could be rescued by wild-type 
proteins provided in Irans. M utations in the N-terminal part of 
poliovirus protein 2B have been reported to cause noncomple- 
mentable defects in vR N A  synthesis (4, 12, 20, 27). However, 
complementation experiments with protein 3A mutants have 
shown that even within one protein, cis-acting and fra/z,v-acting 
functional regions can be discriminated (4 ,16). We found that 
none of the mutations in the hydrophobic domain that caused 
phenotypes in vR N A  synthesis could be efficiently comple­
mented by wild-type protein 2B. Both the N-terminal region 
and the hydrophobic dom ain of protein 2B appear to be in-
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volved in a c/s-acting function in vRNA replication. It is not 
clear whether the effects that are observed upon expression of 
poliovirus protein 2B (i.e., permeabilization of the plasma 
m em brane and inhibition of protein secretion) (13) reflect 
different functions of protein 2B or whether one of these ef­
fects is the consequence of the other. If permeabilizing the 
plasma m em brane were the primary function of the hydropho­
bic domain and if the inhibition of protein secretion were only 
a side effect of this function, then a certain degree of tmns 
complementation should have been expected. The lack of 
complementabiUty does not exclude the possibility that the 
hydrophobic domain is involved in permeabilization of the 
plasma membrane but suggests that the hydrophobic domain is 
also involved in another function of protein 2B in vRNA syn­
thesis.
Several explanations may account for the cis-acting function 
of protein 2B. First, protein 2B may interact directly with the 
E R  m em brane to function in the accumulation or structural 
organization of virus-induced membranous structures around 
the same positive RN A  strand from which it is synthesized. 
This mechanism would ensure a tight linkage between trans­
lation and replication and prevent RNAs other than viral pos­
itive R N A  strands from being replicated by 3Dpo1, which lacks 
template specificity (30). A  second possibility is that wild-type 
2B proteins cannot reach the m utant templates. Replication of 
the vRNA takes places in close conjunction with membranes. 
This membranous environment may interfere with the func­
tional interchange of m utant and wild-type protein 2B. A  third 
possibility is that the m utant 2B proteins interact with a limit­
ing target and that wild-type protein 2B, which is provided 
later, cannot efficiently compete with them. This possibility was 
raised by Johnson and Sarnow (20), who found that poliovirus 
2B mutants exhibited a dosage-dependent dominance over 
wild-type protein 2B. The interaction of the mutant CBV3 2B 
proteins with this limiting target may interfere with the action 
of wild-type protein 2B and thereby account for the lack of 
complementation.
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